skinny.

Latest / The Well-Built Life

Unlocking Cancer’s Sugar Shield: AbLec’s Promise in Immunotherapy

Explore the groundbreaking AbLec technology, developed , designed to target cancer cell glycan interactions. Discuss the mechanisms, stakes, and future outlook, including challenges in clinical application and potential synergy with existing therapies.

📥 Connect with The Well-Built Life

If you enjoyed today’s conversation, please take a moment to follow or subscribe to the channel on your favorite platform so you never miss a practical health and wellness tip.

Spreaker: Spreaker Podcast Link

Business Inquiries: Contact Us

☕ Support the Show

This podcast is completely independent and ad-free…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.